Differentiation of the Gastric Mucosa IV. Role of trefoil peptides and IL-6 cytokine family signaling in gastric homeostasis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 292, Issue 1, 2007, Pages

  Giraud, A S ^a   Jackson, C ^a   Menheniott, T R ^a   Judd, L M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Gastric cancer; Gastric homeostasis; gp130; Interleukin 6; Trefoil peptides

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; TREFOIL PEPTIDE;

ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CELL DIFFERENTIATION; CELL MIGRATION; HOMEOSTASIS; INFLAMMATION; MUCUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH MUCOSA;

ANIMALS; ESTROGENS; GASTRIC MUCOSA; HOMEOSTASIS; HUMANS; INTERLEUKIN-6; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 33846128721     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00382.2006     Document Type: Review

References (26)

1. Baus-Loncar M, Giraud AS. Multiple regulatory pathways for trefoil factor (TFF) genes. Cell Mol Life Sci 62: 2921-2931, 2005.
2. Baus-Loncar M, Kayademir T, Takaishi S, Wang T. Trefoil factor 2 deficiency and immune response. Cell Mol Life Sci 62: 2947-2955, 2005.
3. Bromberg J. Stat proteins and oncogenesis. J Clin Invest 109: 1139-1142, 2002.
4. Clyne M, Dillon P, Daly S, O'Kennedy R, May FE, Westley BR, Drumm B. Helicobacter pylori interacts with the human single-domain trefoil protein TFF1. Proc Natl Acad Sci USA 101: 7409-7414, 2004.
5. Davidson AJ, Freeman SA, Crosier KE, Wood CR, Crosier PS. Expression of murine interleukin 11 and its receptor α-chain in adult and embryonic tissues. Stem Cells 15: 119-124, 1997.
6. Dossinger V, Kayademir T, Blin N, Gott P. Down-regulation of TFF expression in gastrointestinal cell lines by cytokines and nuclear factors. Cell Physiol Biochem 12: 197-206, 2002.
7. Franic TV, van Driel IR, Gleeson PA, Giraud AS, Judd LM. Reciprocal changes in trefoil 1 and 2 expression in stomachs of mice with gastric unit hypertrophy and inflammation. J Pathol 207: 43-52, 2005.
8. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 4: 688-694, 2004.
9. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374: 1-20, 2003.
10. Howlett M, Judd LM, Jenkins BJ, Ernst M, Giraud AS. Differential regulation of gastric tumor growth and submucosal invasion by cytokines that signal exclusively through the co-receptor gp130. Gastroenterology 129: 1005-1018, 2005.
11. Hwang IR, Hsu PI, Peterson LE, Gutierrez O, Kim JG, Graham DY, Yamaoka Y. Interleukin-6 genetic polymorphisms are not related to helicobacter pylori-associated gastroduodenal diseases. Helicobacter 8: 142-148, 2003.
12. Jenkins BJ, Grail D, Nheu T, Naidovska M, Wang B, Waring P, Inglese M, McLoughlin RM, Jones SA, Topley N, Baumann H, Judd LM, Giraud AS, Zhu HJ, Ernst M. Exaggerated STAT3-activity promotes gastric hyper-proliferation in gp130 mutant mice due to desensitized TGFβ signaling. Nat Med 11: 845-852, 2005.
13. Judd LM, Alderman BM, Howlett M, Shulkes A, Dow C, Moverley J, Grail D, Jenkins BJ, Ernst M, Giraud AS. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 126: 196-207, 2004.
14. 13a. Judd LM, Bredin K, Kalantzis, A, Jenkins BJ, Ernst M, Giraud AS. STAT3 activation regulates gastric tumor growth, inflammation and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 131: 1073-1085, 2006.
15. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 149: 1-38, 2003.
16. Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y, Sekikawa A, Kawada M, Suzuki K, Kayahara T, Fukui H, Sawada M, Chiba T. STAT3 is constitutively activated and supports cell survival in associated with surviving expression in gastric cancer cells. Oncogene 23: 4921-4929, 2004.
17. Kato S, Matsukura N, Togashi A, Masuda G, Masuda N, Yamada N, Naito Z, Matsuhisa T, Tajiri T. Sex differences in mucosal response to Helicobacter pylori infection in the stomach and variations in interleukin 8, COX-2, and trefoil factor 1 gene expression. Aliment Pharmacol Ther 20, Suppl 1: 17-24, 2004.
18. Park WS, Oh RR, Park JY, Lee JH, Shin MS, Kim HS, Lee HK, Kim YS, Kim SY, Lee SH, Yoo NY, Lee JY. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 119: 691-698, 2000.
19. Regalo G, Wright NA, Machado JC. Trefoil factors: from ulceration to neoplasia. Cell Mol Life Sci 62: 2910-2915, 2005.
20. Ruchaud-Sparagano MH, Westley BR, May FE. The trefoil protein TFF1 is bound to MUC5AC in human gastric mucosa. Cell Mol Life Sci 61: 1946-1954, 2004.
21. Sankpal NV, Mayo MW, Powell SM. Transcriptional repression of TFF1 in gastric epithelial cells by CCAT/enhancer binding protein-β. Biochim Biophys Acta 1728: 1-10, 2005.
22. Tebbutt NC, Giraud AS, Inglese M, Waring P, Jenkins B, Clay FJ, Malki S, Grail D, Hollande F, Heath JK, Ernst M. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 8: 1089-1097, 2002.
23. Taupin DR, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4: 721-733, 2003.
24. Tomasetto C, Rio MC. Pleiotropic effects of trefoil actor 1 deficiency. Cell Mol Life Sci 62: 2916-2920, 2005.
25. Van De Bovenkamp JH, Korteland-Van Male AM, Buller HA, Einerhand AW, Dekker J. Infection with Helicobacter pylori affects all major secretory cell populations in the human antrum. Dig Dis Sci 50:1078-1086, 2005.
26. Yio X, Diamond M, Zhang JY, Weinstein H, Wang LH, Werther L, Itzkowitz S. Trefoil factor-family 1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. Gastroenterology 130:1696-1706, 2006.